MPLTMapLight Therapeutics, Inc.
What is the market doing?
No clear lean: nothing decisive, though in a downtrend (−62% vs 200-day).
In a downtrend, below its 50- and 200-day averages. Price is −62% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 22, 2026; selling is often routine (taxes, diversification).
Moderately shorted, settled Sep 30, 2026, about a week of normal trading to cover. Down 4.5% since the previous count, up from 5.7% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How MPLT is trading
- vs 200-day average
- −62%
vs 200-day average · a clear downtrend
- RSI (14)
- 33
RSI (14) · neutral
- Below its 52-week high
- 80%
Below its 52-week high
Details›
- Last close2026-10-23
- $7.96
- 1 monthS&P 500 −0.94%
- −26%
- vs 50-day average$10.82
- −26%
- 52-week high
- $39.80
- 52-week low
- $7.70
- Annualised volatility
- 111%
- Insider selling, net, 6 monthsForms 3/4/5 to 2026-10-22
- $7.6M
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
Biotechnology
The closest names by size in the same industry